$0.000001
0.000.00%
At close: -
Comments
Loading...
North American Cannabis Analyst Ratings and Price Targets | OTC:USMJ | Benzinga
North American Cannabis Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for North American Cannabis Corp from these most-recent analyst ratings.
Analyst Ratings for North American Cannabis
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for North American Cannabis (USMJ) stock?
There is no price target for North American Cannabis
What is the most recent analyst rating for North American Cannabis (USMJ)?
There is no analyst for North American Cannabis
When was the last upgrade for North American Cannabis (USMJ)?
There is no last upgrade for North American Cannabis
When was the last downgrade for North American Cannabis (USMJ)?
There is no last downgrade for North American Cannabis.
When is the next analyst rating going to be posted or updated for North American Cannabis (USMJ)?
There is no next analyst rating for North American Cannabis.
Is the Analyst Rating North American Cannabis (USMJ) correct?
There is no next analyst rating for North American Cannabis.
Browse analyst ratings and price targets on all stocks.